ARCHIVES

NCI Receives 165 SBIR Grant Applications; Combines With Solid Contracts, No More Fiascos Are Expected

This article is from The Cancer Letter archive.

Vol. 11 No. 24 | June 14, 1985

Download PDF Visit The Full Archive

Related Articles

Freireich’s Seven Laws To Protect Against Obstacles To Clinical Research

May 14, 1976

Senators Urge study section On Clinical Cancer Research

February 4, 1994

In Brief: Knowledge Surgeons, Radiotherapists, Pathologists Untapped, Zubrod Suggests

February 20, 1976

In Brief: NCI Recieves Two Proposals For Antineoplaston Trials, None For Children; Stubble Elected To NAS

June 19, 1992

PRI’s Frederick Fee $903,866 For First Six Months Of New Contract

September 2, 1988

Bristol-Myers Squibb Co. has agreed to pay $450 million to settle class action suits from shareholders and separate civil claims by the Securities and Exchange Commission. The settlements stem from Bristol’s practice of building up wholesalers’ inventories and diverting operating income to enhance dividends.

August 6, 2004